Fresenius Medical Care (FMS) Tops Q1 EPS by 33c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community
May 2, 2016 9:51 AM EDTWALTHAM, Mass.--(BUSINESS WIRE)-- Fresenius Renal Therapies, a division of Fresenius Medical Care North America (FMCNA), the leading provider of products and services for the chronic kidney disease patient, announced today the introduction of its latest technological enhancement in the Crit-Line® technology product line, the CLiC device.
The CLiC device non-invasively measures hematocrit, oxygen saturation and percent change in intravascular blood volume during a patients hemodialysis (HD) treatment. As an integrated feature in the 2008T hemodialysis machine, the organizations flagship HD delivery system, the healthcare professional has immediate, real-time access to a patients hematocrit, percent... More
